The Journal of clinical investigation

Brain GLP1R helps liraglutide reduce appetite but not blood sugar

Updated

Abstract

Liraglutide treatment lowered glucose levels in mice lacking GLP1 receptors in the brain and visceral nerves.

  • Both glucose levels and body weight are regulated by the brain through GLP1 receptors.
  • Mice with specific deletions of GLP1 receptors in neurons or visceral nerves showed no change in body weight or food intake with liraglutide treatment.
  • Liraglutide effectively reduced glucose levels in chow- and high-fat-fed mice, regardless of GLP1 receptor presence in the CNS or visceral nerves.
  • Neuronal GLP1 receptors are associated with the body weight and appetite-suppressing effects of liraglutide.
  • GLP1 receptors in the brain are not necessary for the glucose-lowering effects of liraglutide.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free